Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients

High-grade osteosarcoma has a poor prognosis with an overall survival rate of about 60 percent. The recently closed European and American Osteosarcoma Study Group (EURAMOS)-1 trial investigates the efficacy of adjuvant chemotherapy with or without interferon-α. It is however unknown whether the inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Buddingh, Emilie P., Ruslan, S. Eriaty N., Berghuis, Dagmar, Gelderblom, Hans, Anninga, Jakob K., Hogendoorn, Pancras C. W., Egeler, R. Maarten, Schilham, Marco W., Lankester, Arjan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362707/
https://www.ncbi.nlm.nih.gov/pubmed/22402907
http://dx.doi.org/10.1007/s00262-012-1232-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362707/
https://www.ncbi.nlm.nih.gov/pubmed/22402907
http://dx.doi.org/10.1007/s00262-012-1232-6

Ejemplares similares